Disaster! Five Hospitalized with One Brain Dead in Bial’s French Clinical Trial

Disaster! Five Hospitalized with One Brain Dead in Bial’s French Clinical Trial

A clinical trial in France of an experimental drug made by Portuguese drug company Bial has resulted out in devastating results when given to patients. A total of 90 people took part in the trial, taking some dosage of the drug aimed at tackling mood and anxiety issues, as well as movement coordination disorders linked to neurological issues. Marisol Touraine, French Health Minister, said the case to be unprecedented when she was reported that the oral medication by the Biotrial private facility led five people hospitalized with the one left brain dead. The medicine involved in the trial is a so-called FAAH inhibitor that works by targeting the body's endocannabinoid system, which is also responsible for the human response to cannabis.

Touraine said that they will go deep in the case to understand what has actually happened. She added that all the six participants were given the trial drug on Jan 7, but the brain dead participant was being admitted to hospital on Monday. Gilles Edan, doctor, said that there were fears of irreversible handicap for three of the five others, who went in on Wednesday and Thursday. It was not the case that the drug was being tested for the first time on humans, testing has already been performed on animals, including chimpanzees, starting in July.

According to the statement by the health ministry, all the trails on the drug have been suspended and all the volunteers who have taken part in the trail are called back. In a defensive statement from the company, Bial said that the drug was committed to ensure the wellbeing of test participants and was working with authorities to discover the cause of the injuries, adding that the clinical trial have been approved by French regulators. Moreover, the company added that five people, rather than six, had been hospitalized, including one left brain dead.

Health